Use of IVIg to identify potential miRNA targets for allograft rejection and GvHD therapy.

Padet, Lauriane

Use of IVIg to identify potential miRNA targets for allograft rejection and GvHD therapy. [electronic resource] - Clinical transplantation Jun 2015 - 543-6 p. digital

Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't

1399-0012

10.1111/ctr.12549 doi


Allografts--immunology
B7-1 Antigen--genetics
Biomarkers--metabolism
Cytokines--genetics
Gene Expression Regulation--drug effects
Graft Rejection--genetics
Graft vs Host Disease--genetics
Humans
Immunoglobulins, Intravenous--pharmacology
Lymphocyte Culture Test, Mixed
MicroRNAs--metabolism